References

Allsbrook Jr, William C, Kathy A Mangold, Mark H Johnson, Richard B Lane, Charles G Lane, Mahul B Amin, David G Bostwick, et al. 2001. “Interobserver Reproducibility of Gleason Grading of Prostatic Carcinoma: General Pathologist.” Urology 57 (1): 81–88.

Baidoshvili, Alexi, Mariam Kacheishvili, Jeroen van der Laak, and Paul van Diest. 2021. “A Whole-Slide Imaging Based Workflow Reduces the Reading Time of Pathologists.” Research Square, May. https://doi.org/10.21203/rs.3.rs-520449/v1.

Bulten, Wouter, Kimmo Kartasalo, Po-Hsuan Cameron Chen, Peter Ström, Hans Pinckaers, Kunal Nagpal, Yuannan Cai, et al. 2022. “Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer: The PANDA Challenge.” Nature Medicine 28 (1): 154–63. https://doi.org/10.1038/s41591-021-01620-2.

Campanella, Gabriele, Matthew G Hanna, Luke Geneslaw, Allen Miraflor, Vitor Werneck Krauss Silva, Klaus J Busam, Edi Brogi, Victor E Reuter, David S Klimstra, and Thomas J Fuchs. 2019. “Clinical-Grade Computational Pathology Using Weakly Supervised Deep Learning on Whole Slide Images.” Nature Medicine 25 (8): 1301–9.

Eloy, Catarina, Ana Marques, João Pinto, Jorge Pinheiro, Sofia Campelos, Mónica Curado, João Vale, and António Polónia. 2023. “Artificial Intelligenceassisted Cancer Diagnosis Improves the Efficiency of Pathologists in Prostatic Biopsies.” Virchows Archiv 482 (2): 375–83. https://doi.org/10.1007/s00428-023-03518-5.

Epstein, Jonathan I, Zhaoyong Feng, Bruce J Trock, and Phillip M Pierorazio. 2012. “Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades.” European Urology 61 (5): 1019–24.

Esteva, Andre, Jean Feng, Douwe van der Wal, et al. 2022. “Prostate Cancer Therapy Personalization via Multi-Modal Deep Learning on Randomized Phase III Clinical Trials.” Npj Digital Medicine 5 (71). https://doi.org/10.1038/s41746-022-00613-w.

Evans, Harriet, and David Snead. 2023. “Why Do Errors Arise in Artificial Intelligence Diagnostic Tools in Histopathology and How Can We Minimize Them?” Histopathology. https://doi.org/10.1111/his.15071.

Faryna, Khrystyna, Leslie Tessier, Juan Retamero, Saikiran Bonthu, Pranab Samanta, Nitin Singhal, Solene-Florence Kammerer-Jacquet, et al. 2024. “Evaluation of Artificial Intelligence-Based Gleason Grading Algorithms "in the Wild".” Modern Pathology 37: 100563. https://doi.org/10.1016/j.modpat.2024.100563.

Flach, Rachel N, Nikolas Stathonikos, Tri Q Nguyen, Natalie D Ter Hoeve, Paul J van Diest, and Carmen van Dooijeweert. 2023. “CONFIDENT-Trial Protocol: A Pragmatic Template for Clinical Implementation of Artificial Intelligence Assistance in Pathology.” BMJ Open 13 (6): e067437. https://doi.org/10.1136/bmjopen-2022-067437.

Flach, Rachel N, Peter-Paul M Willemse, Britt BM Suelmann, Ivette AG Deckers, Trudy N Jonges, Carmen van Dooijeweert, Paul J van Diest, and Richard P Meijer. 2021. “Significant Inter- and Intralaboratory Variation in Gleason Grading of Prostate Cancer: A Nationwide Study of 35,258 Patients in the Netherlands.” Cancers 13 (21): 5378.

Haghighat, Maryam, Lisa Browning, Korsuk Sirinukunwattana, Stefano Malacrino, Nasullah Khalid Alham, Richard Colling, Ying Cui, et al. 2022. “Automated Quality Assessment of Large Digitised Histology Cohorts by Artificial Intelligence.” Scientific Reports 12 (1). https://doi.org/10.1038/s41598-022-08351-5.

Hanna, Matthew G, Victor E Reuter, Meera R Hameed, Lee K Tan, Sarah Chiang, Carlie Sigel, et al. 2019. “Whole Slide Imaging Equivalency and Efficiency Study: Experience at a Large Academic Center.” Modern Pathology 32 (7): 916–28.

Janowczyk, Andrew, Patrick Leo, and Mark A Rubin. 2020. “Clinical Deployment of AI for Prostate Cancer Diagnosis.” The Lancet Digital Health 2 (8): e383–84.

Jung, H, HS Ryu, JS Park, et al. 2022. “Artificial Intelligence System Shows Performance at the Level of Uropathologists for the Detection and Grading of Prostate Cancer in Core Needle Biopsy: An Independent External Validation Study.” Modern Pathology 35: 1296–1304.

Kartasalo, Kimmo, Wouter Bulten, Brett Delahunt, Po-Hsuan Cameron Chen, Hans Pinckaers, Henrik Olsson, Xiaoyi Ji, et al. 2021. “Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer in Biopsies—Current Status and Next Steps.” European Urology Focus 7 (4): 687–91.

Marrón-Esquivel, José M, L Duran-Lopez, A Linares-Barranco, and Juan P Dominguez-Morales. 2023. “A Comparative Study of the Inter-Observer Variability on Gleason Grading Against Deep Learning-Based Approaches for Prostate Cancer.” Computers in Biology and Medicine 159: 106856.

Melia, J, R Moseley, RY Ball, DFR Griffiths, K Grigor, P Harnden, M Jarmulowicz, et al. 2006. “A UK-Based Investigation of Inter- and Intra-Observer Reproducibility of Gleason Grading of Prostatic Biopsies.” Histopathology 49 (4): 411–17.

Mittmann, Finn, Jonas Müller, Jonas Krause, et al. 2025. “Pathologist-Like Explainable AI for Interpretable Gleason Grading in Prostate Cancer.” Nature Communications 16: 8959. https://doi.org/10.1038/s41467-025-64712-4.

Mottet, N., P. Cornford, R. C. N. van den Bergh, E. Briers, M. De Santis, S. Fanti, et al. 2025. “EAU Guidelines on Prostate Cancer.” European Association of Urology. https://uroweb.org/guidelines/prostate-cancer.

Nakai, Yasushi, Nobumichi Tanaka, Satoshi Anai, Makoto Miyake, Yoshihiko Tatsumi, Tomomi Fujii, Keiji Nobumori, et al. 2015. “Interobserver Variability in Gleason Histological Grading of Prostate Cancer.” Urologia Internationalis 95 (3): 313–18.

Nakai, Yasushi, Nobumichi Tanaka, Keiji Shimada, Noboru Konishi, Makoto Miyake, Satoshi Anai, and Kiyohide Fujimoto. 2015. “Review by Urological Pathologists Improves the Accuracy of Gleason Grading by General Pathologists.” BMC Urology 15 (1): 70.

Ozkan, Tayyar Alp, Asli Tuncer Eruyar, Omer Ones Cebeci, Oztug Memik, Gulsah Lezgin, and Ibrahim Kuskonmaz. 2016. “Interobserver Variability in Gleason Histological Grading of Prostate Cancer.” Scandinavian Journal of Urology 50 (6): 420–24.

Paige.AI. 2022. “Paige AI & Sectra Integration: 3 Delivery Options.” Internal Document.

Pantanowitz, Liron, G Quiroga-Garza, L Bien, R Heled, D Laifenfeld, C Linhart, J Sandbank, et al. 2020. “An Artificial Intelligence Algorithm for Prostate Cancer Diagnosis in Whole Slide Images of Core Needle Biopsies: A Blinded Clinical Validation and Deployment Study.” The Lancet Digital Health 2 (8): e407–16.

Perincheri, S, AW Levi, S Cammack, et al. 2021. “An Independent Assessment of an Artificial Intelligence System for Prostate Cancer Detection Shows Strong Diagnostic Accuracy.” Modern Pathology 34: 1574–83.

Raciti, Patricia, Jillian Sue, Rodrigo Ceballos, Ran Godrich, Jeremy D. Kunz, Supriya Kapur, Victor Reuter, et al. 2020. “Novel Artificial Intelligence System Increases the Detection of Prostate Cancer in Whole Slide Images of Core Needle Biopsies.” Modern Pathology 33 (10): 2058–66. https://doi.org/10.1038/s41379-020-0551-y.

Raciti, Patricia, Jillian Sue, Juan A. Retamero, Rodrigo Ceballos, Ran Godrich, Jeremy D. Kunz, Adam Casson, et al. 2023. “Clinical Validation of Artificial IntelligenceAugmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection.” Archives of Pathology & Laboratory Medicine 147 (10): 1178–85. https://doi.org/10.5858/arpa.2022-0066-oa.

Salmo, Emile N. 2015. “An Audit of Inter-Observer Variability in Gleason Grading of Prostate Cancer Biopsies: The Experience of Central Pathology Review in the North West of England.” Integrative Cancer Science and Therapeutics 2 (2): 104–6. https://doi.org/10.15761/ICST.1000123.

Silva, K de, K Lawler, A Gertych, et al. 2021. “Independent Real-World Application of a Clinical-Grade Automated Prostate Cancer Detection System.” The Journal of Pathology 254 (2): 147–58.

Singh, R, D Cahill, R Popert, and TS O’Brien. 2011. “Interobserver Reproducibility of Gleason Grading of Prostatic Adenocarcinoma Among General Pathologists.” Histopathology 58 (3): 455–60.

Spratt, Daniel E., Siyi Tang, Yilun Sun, et al. 2023. “Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer.” NEJM Evidence 2 (8). https://doi.org/10.1056/EVIDoa2300023.

Steiner, David F, Kunal Nagpal, Rory Sayres, Ellery Foote, Jonathan D Wren, Greg S Corrado, Lily H Peng, Yun Liu, et al. 2020. “Evaluation of the Use of Combined Artificial Intelligence and Pathologist Assessment to Review and Grade Prostate Biopsies.” JAMA Network Open 3 (11): e2023267.

U.S. Food and Drug Administration. 2021. “FDA Authorizes Software That Can Help Identify Prostate Cancer.” Press Release. https://www.fda.gov/news-events/press-announcements/fda-authorizes-software-can-help-identify-prostate-cancer.

World Health Organization. 2024. “Global Cancer Burden Growing, Amidst Mounting Need for Services.” Press Release. https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services.